An insight into the diverse roles of surfactant proteins, SP-A and SP-D in innate and adaptive immunity

Frontiers in Immunology

Volumn 3, Issue JUN, 2012, Pages

  Nayak, Annapurna ^a,b   Dodagatta Marri, Eswari ^a   Tsolaki, Anthony George ^a   Kishore, Uday ^a  

^a BRUNEL UNIVERSITY   (United Kingdom)

^b Jawaharlal Nehru Institute for Advanced Study   (India)

Author keywords

Hypersensitivity; Infection; Innate immunity; Macrophage; Pattern recognition receptor; Surfactant

Indexed keywords

EID: 84871710260     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00131     Document Type: Review

References (221)

1. Akiyama, J., Hoffman, A., Brown, C., Allen, L., Edmondson, J., Poulain, F., and Hawgood, S. (2002). Tissue distribution of surfactant proteins A and D in the mouse. J. Histochem. Cytochem. 2002, 993-996.
2. Akman, A., Kankavi, O., Ciftcioglu, M., and Alpsoy, E. (2008). Surfactant proteins in inflammatory skin dis-eases: controlled study. Arch. Dermatol. Res. 300, 353-356.
3. Alcorn, J., and Wright, J. (2004a). Degradation of pulmonary surfactant protein D by Pseudomonas aeruginosa elastase abrogates innate immune function. J. Biol. Chem. 279, 30871-30879.
4. Alcorn, J., and Wright, J. (2004b). SSurfactant protein A inhibits alveolar macrophage cytokine production by CD14-independent pathway. Am. J. Physiol. Lung Cell. Mol. Physiol. 286, L129-36.
5. Allen, M., Voelker, D., and Mason, R. (2001). Interactions of surfactant proteinsA and D with Saccharomyces cerevisiae and Aspergillus fumigatus. Infect. Immun. 69, 2037-2044.
6. Asano, Y., Ihn, H., Yamane, K., Yazawa, N., Kubo, M., Fujimoto, M., and Tamaki, K. (2001). Clinical sig-nificance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis. Arthritis Rheum. 44, 1363-1369.
7. Awasthi, S., Coalson, J., Yoder, B., Crouch, E., and King, R. (2001). Deficiencies in lung surfactant proteins A and D are associated with lung infection in very premature neonatal baboons.Am. J. Respir. Crit. Care Med. 163, 389-397.
8. Awasthi, S., Magee, D., and Coalson, J. (2004). Coccidioides posadasii infection alters the expression of pulmonary surfactant proteins (SP)-A and SP-D. Respir. Res. 5, 28-33.
9. Barlo, N., van Moorsel, C., Ruven, H., Zanen, P., van den Bosch, J., and Grutters, J. (2009). Surfactant protein-D predicts survival in patients with idiopathic pulmonary fibrosis. Sarcoidosis Vasc. Diffuse Lung Dis. 26, 155-161.
10. Barr, F. E., Pedigo, H., Johnson, T. R., and Shepherd, V. L. (2000). Surfactant protein-A enhances uptake of respiratory syncytial virus by monocytes and U937 macrophages. Am. J. Respir. Cell Mol. Biol. 23, 586-592.
11. Beharka, A., Gaynor, C., Kang, B., Voelker, D., McCormack, F., and Schlesinger, L. (2002). Pulmonary surfactant protein A upregulates activity of the mannose receptor, a pattern recognition receptor expressed on human macrophages. J. Immunol. 169, 3565-3573.
12. Benne, C., Kraaijeveld, C., van Strijp, J., Brouwer, E., Harmsen, M., Verhoef, J., van Golde, L. M., and van Iwaar-den, J. F. (1995). Interactions of sSurfactant protein A with influenza Aviruses: binding and neutralization. J. Infect. Dis. 171, 335-341.
13. Bernal, A., and Phizackerley, P. (2000). Fetal surfactant as a source of arachi-donate in human amniotic fluid. Prostaglandins Other Lipid Mediat. 60, 59-70.
14. Bianchi, S. M., Prince, L. R., McPhillips, K., Allen, L., Marriott, H. M., and Taylor, G. W. (2008). Impairment of apoptotic cell engulfment by pyocyanin, a toxic metabolite of Pseudomonas aeruginosa. Am. J. Respir. Crit. Care Med. 177, 35-43.
15. Borron, P., McIntosh, J., Korfhagen, T., Whitsett, J., Taylor, J., and Wright, J. (2000). Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo. Am. J. Physiol. Lung Cell. Mol. Phys-iol. 278, L840-L847.
16. Brauer, L., Kindler, C., Jäger, K., Sel, S., Nölle, B., Pleyer, U., Ochs, M., and Paulsen, F. P. (2007). Detection of surfactant proteins A and D in human tear fluid and the human lacrimal system. Invest. Ophthalmol. Vis. Sci. 48, 3945-3953.
17. Breuiller-Fouche, M., Dubois, O., Sediki, M., Garcia-Verdugo, I., Palaniyar, N., Tanfin, Z., Chissey, A., Cabrol, D., Charpigny, G., and Mehats, C. (2010). Secreted surfactant protein A from fetal membranes induces stress fibers in cultured human myometrial cells. Am. J. Physiol. Endocrinol. Metab. 298, E1188-E1197.
18. Brinker, K. G., Garner, H., and Wright, J. R. (2003). Surfactant protein A modulates the differentiation of murine bone marrow-derived den-dritic cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 284, L232-L241.
19. Brinker, K. G., Martin, E., Borron, P., Mostaghel, E., Doyle, C., Harding, C. V., and Wright, J. R. (2001). SSurfactant protein D enhances bacte-rial antigen presentation by bone marrow-derived dendritic cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 281, L1453-L1463.
20. Brown, A., Quinn, M., Karim, Z., Conaghan, P., Peterfy, C., Hensor, E., Wakefield, R. J., O'Connor, P. J., and Emery, P. (2006). Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression. Arthritis Rheum. 54, 3761-3773.
21. Bruce, S. R., Atkins, C. L., Colasurdo, G. N., and Alcorn, J. L. (2009). Respiratory syncytial virus infection alters surfactant protein A expression in human pulmonary epithelial cells by reducing translation efficiency. Am. J. Physiol. Lung Cell. Mol. Physiol. 297, L559-L567.
22. Chailley-Heu, B., Rubio, S., Rougier, J. P., Ducroc, R., Barlier-Mur, A. M., Ronco, P., and Bourbon, J. R. (1997). Expression of hydrophilic surfactant proteins by mesentery cells in rat and man. Biochem. J. 328, 251-256.
23. Chaiworapongsa, T., Hong, J., Hull, W., Kim, C., Gomez, R., Mazor, M., Romero, R., and Whitsett, J. A. (2008). The concentration of sSurfactant protein-A in amniotic fluid decreases in spontaneous human parturition at term. J. Matern. Fetal Neonatal Med. 2008, 652-659.
24. Challis, J., Bloomfield, F., Bocking, A., Casciani, V., Chisaka, H., Connor, K., Dong, X., Gluckman, P., Hard-ing, J. E., Johnstone, J., Li, W., Lye, S., Okamura, K., and Premyslova, M. (2005). Fetal signals and parturition. J. Obstet. Gynaecol. Res. 31, 492-499.
25. Chiba, H., Pattanajitvilai, S., Evans, A., Harbeck, R., and Voelker, D. (2002). Human surfactant protein D (SP-D) binds Mycoplasma pneu-monia by high affinity interactions with lipids. J. Biol. Chem. 277, 20379-20385.
26. Christensen, A., Sørensen, G., Hørslev-Petersen, K., Holmskov, U., Linde-gaard, H. M., Junker, K., Hetland, M. L., Stengaard-Pedersen, K., Jacobsen,S.,Lottenburger,T.,Ellingsen,T., Andersen, L. S., Hansen, I., Skjødt, H., Pedersen, J. K., Lauridsen, U. B., Svendsen, A., Tarp, U., Pødenphant, J., Vestergaard, A., Jurik, A. G., Østergaard, M., and Pand, J. (2010). Circulating surfactant protein-D is low and correlates nega-tively with systemic inflammation in early, untreated rheumatoid arthritis. Arthritis Res. Ther. 12, R39.
27. Chroneos, Z., Abdolrasulnia, R., Whitsett, J., Rice, W., and Shepherd, V. (1996). Purification of a cell-surface receptor for surfactant protein A. J. Biol. Chem. 271, 16375-16383.
28. Clark, H., and Reid, K. (2002). Structural requirements for SP-D function in vitro and in vivo: therapeutic potential of recombinant SP-D. Immunobiology 205, 619-631.
29. Condon, J., Jeyasuria, P., Faust, J., and Mendelson, C. (2004). Surfactant protein secreted by the maturing mouse fetal lung acts as a hormone that signals the initiation of parturition. Proc. Natl. Acad. Sci. U.S.A. 101, 4978-4983.
30. Crouch, E., and Wright, J. R. (2001). Surfactant proteins a and d and pulmonary host defense. Annu. Rev. Physiol. 63, 521-554.
31. Crouch, E. C. (2000). Surfactant protein-D and pulmonary host defense. Respir. Res. 1, 93-108.
32. Dahl, M., Holmskov, U., Husby, S., and Juvonen, P. (2006). Surfactant protein D levels in umbilical cord blood and capillary blood of premature infants. The influence of perinatal factors. Pediatr. Res. 59, 806-810.
33. Dahl,M.,Juvonen,P.,Holmskov,U.,and Husby, S. (2005). Surfactant protein D in newborn infants: factors influ-encing surfactant protein D levels in umbilical cord blood and capillary blood. Pediatr. Res. 58, 908-912.
34. Dobbie, J., Hind, C., Meijers, P., Bodart, C., Tasiaux, N., Perret, J., and Anderson, J. D. (1995). Lamellar body secretion: ultrastructural analysis of an unexplored function of synovio-cytes. Br. J. Rheumatol. 34, 13-23.
35. Dobbie, J. W. (1996). Surfactant protein A and lamellar bodies: a homologous secretory function of peritoneum, synovium, and lung. Perit. Dial. Int. 16, 574-581.
36. Dobbie, J. W., Tasiaux, N., Meijers, P., Anderson, J. D., Bodart, C., Hind, C., Bourguet, C., and Perret, J. (1994). Lamellar bodies in synoviocytes, mesothelium and specific epithelia as possible site of auto-antigen in rheumatoid disease. Br. J. Rheumatol. 6, 508-519.
37. Downing, J. F., Pasula, R., Wright, J. R., Twigg, H. L., and Mar-tin, W. J. (1995). Surfactant protein a promotes attachment of Mycobacterium tuberculosis to alveolar macrophages during infection with human immunodeficiency virus. Proc. Natl. Acad. Sci. U. S. A. 92, 4848-4852.
38. Dulkerian, S., Gonzales, L., Ning,Y., and Ballard, P. (1996). Regulation of sSurfactant protein D in human fetal lung. Am. J. Respir. Cell Mol. Biol. 15, 781-786.
39. Eisner, M., Parsons, P., Matthay, M., Ware, L., and Greene, K. (2003). Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury. Thorax 58, 983-988.
40. Erpenbeck, V., Malherbe, D., Sommer, S., Schmiedl, A., Steinhilber, W., Ghio, A. J., Krug, N., Wright, J. R., and Hohlfeld, J. M. (2005). SSurfactant protein D increases Phagocytosis and aggregation of pollen-allergen starch granules. Am.J.Phys-iol. Lung Cell. Mol. Physiol. 288, L692-L698.
41. Erpenbeck, V., Ziegert, M., Cavalet-Blanco, D., Martin, C., Baelder, R., Glaab, T., Braun, A., Steinhilber, W., Luettig, B., Uhlig, S., Hoymann, H. G., Krug, N., and Hohlfeld, J. M. (2006). Surfactant protein D inhibits early airway response in Aspergillus fumigatus-sensitized mice. Clin. Exp. Allergy 36, 930-940.
42. Ferguson, J., Voelker, D., McCor-mack, F., and Schlesinger, L. (1999). Surfactant protein D binds to Mycobacterium tuberculosis bacilli and lipoarabinomannan via carbohydrate-lectin interactions resulting in reduced phagocytosis of the bacteria by macrophages. J. Immunol. 163, 312-321.
43. Ferguson, J., Voelker, D., Ufnar, J., Dawson, A., and Schlesinger, L. (2002). Surfactant protein D inhibition of human macrophage uptake of Mycobacterium tuberculosis is independent of bacterial agglutination. J. Immunol. 168, 1309-1314.
44. Fisher, J., and Mason, R. (1995). Expression of pulmonary surfactant protein D in rat gastric mucosa. Am. J. Respir. Cell Mol. Biol. 12, 13-18.
45. Fujii, M., Tanaka, H., Kameda, M., Fujii, M., Tanaka, S., Ohashi, K., Chiba, H., Takahashi, H., and Abe, S. (2004). Elevated serum surfactant protein A and D in a case of acute eosinophilic pneumonia. Intern. Med. 43, 423-426.
46. Gaiha, G. D., Dong, T., Palaniyar, N., Mitchell, D. A., Reid, K. B., and Clark, H. W. (2008). Surfactant protein A binds to HIV and inhibits direct infection of CD4 + cells, but enhances dendritic cell-mediated viral transfer. J. Immunol. 181, 601-609.
47. Gardai, S., Xiao,Y., Dickinson, M., Nick, J., Voelker, D., Greene, K., and Hen-son, P. (2003). By binding SIRPα or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 115, 13-23.
48. Gaynor, C., McCormack, F., Voelker, D., McGowan, S., and Schlesinger, L. (1995). Pulmonary surfactant protein A mediates enhanced Phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. J. Immunol. 155, 5343-5351.
49. George, C., Goss, K., Meyerholz, D., Lamb, F., and Snyder, J. (2008). Surfactant-associated protein A pro-vides critical immunoprotection in neonatal mice. Infect. Immun. 76, 380-389.
50. Geunes-Boyer, S., Oliver, T. N., Janbon, G., Lodge, J. K., and Heit-man, J. (2009). Surfactant protein D increases phagocytosis of hypocapsular Cryptococcus neoformans by murine macrophages and enhances fungal survival. Infect. Immun. 7, 2783-2794.
51. Ghildyal, R., Hartley, C., Varrasso, A., Meanger, J., Voelker, D. R., Anders, E. M.,and Mills,J. (1999). Surfactant protein A binds to the fusion glyco-protein of respiratory syncytial virus and neutralizes virion infectivity. J. Infect. Dis. 180, 2009-2013.
52. Gibb, W. (1998). The role of prostaglandins in human parturition. Ann. Med. 30, 235-241.
53. Giles, S., Zaas, A., Reidy, M., Perfect, J., and Wright, J. (2007). Cryptococcus neoformans is resistant to surfactant protein A mediated host defense mechanisms. PLoS ONE 2, e1370. doi:10.1371/journal.pone.0001370
54. Greene, K. E., Wright, J. R., Steinberg, K. P., Ruzinski, J. T., Cald-well, E., Wong, W. B., Hull, W., Whitsett, J. A., Akino, T., Kuroki, Y., Nagae, H., Hudson, L. D., and Martin, T. R. (1999). Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am. J. Respir. Crit. Care Med. 160, 1843-1850.
55. Greertsma, M. F., Nibbering, P. H., Haagsman, H. P., Daha, M. R., and van Furth, R. (1994). Binding of sSurfactant protein A to C1q receptors mediates phagocytosis of Staphylo-coccus aureus by monocytes. Am. J. Physiol. 267, L578-L584.
56. Guo, C., Atochina-Vasserman, E., Abramova, E., Foley, J., Zaman, A., Crouch, E., Beers, M. F., Savani, R. C., and Gow, A. J. (2008). S-nitrosylation of surfactant protein-D controls inflammatory function. PLoS Biol. 6, e266. doi:10.1371/journal.pbio.0060266
57. Haczku, A., Cao, Y., Vass, G., Kierstein, S., Nath, P., Atochina-Vasserman, E. N., Scanlon, S. T., and Li, L. (2006). IL-4 and IL-13 form a negative feed-back circuit with surfactant protein-D in the allergic airway response. J. Immunol. 176, 3557-3565.
58. Harrod, K. S., Trapnell, B. C., Otake, K., Korfhagen, T. R., and Whitsett, J. A. (1999). SP-A enhances viral clearance and inhibits inflammation after pulmonary adenoviral infection. Am. J. Physiol. 277(3 Pt 1), L580-L588.
59. Hartshorn, K., Crouch, E., White, M., Eggleton, P., Tauber, A., Chang, D., and Sastry, K. (1994). Evidence for a protective role of pulmonary sSurfactant protein D (SP-D) against influenzaA viruses. J. Clin. Invest. 94, 311-319.
60. Hartshorn, K. L., Crouch, E., White, M. R., Colamussi, M. L., Kakkanatt, A., Tauber, B., Shepherd, V., and Sastry, K. N. (1998). Pulmonary surfactant proteins A and D enhance neutrophil uptake of bacteria. Am. J. Physiol. 274, L958-L969.
61. Hartshorn, K., White, M., Voelker, D., Coburn, J., Zaner, K., and Crouch, E. (2000). Mechanism of binding of surfactant protein D to influenza A viruses: importance of binding to haemagglutinin to antiviral activity. Biochem. J. 351(Pt 2), 449-458.
62. Haslett, C., Savill, J. S., Whyte, M. K., Stern, M., Dransfield, I., and Meagher, L. C. (1994). Granulocyte apoptosis and the control of inflam-mation. Philos. Trans. R. Soc. Lond. B Biol. Sci. 345, 327-333.
63. Herias, M., Hogenkamp, A., van Asten, A., Tersteeg, M., van Eijk, M., and Haagsman, H. (2007). Expression sites of the collectin SP-D sug-gest its importance in first line host defence: power of combin-ing in situ hybridisation, RT-PCR and immunohistochemistry. Mol. Immunol. 44, 3324-3332.
64. Hickling, T. P., Bright, H., Wing, K., Gower, D., Martin, S. L., Sim, R. B., and Malhotra, R. (1999). A recom-binant trimeric surfactant protein D carbohydrate recognition domain inhibits respiratory syncytial virus infection in vitro and in vivo. Eur. J. Immunol. 29, 3478-3484.
65. Hickman-Davis, J., Lindsey, J., Zhu, S., and Matalon, S. (1998). Surfactant protein A mediates mycoplasmaci-dal activity of alveolar macrophages. Am. J. Physiol. 274, L270-L277.
66. Hoegh, S., Lindegaard, H., Sorensen, G., Høj, A., Bendixen, C., Junker, P., and Holmskov, U. (2008). Circulating surfactant protein D is decreased in early rheumatoid arthritis: a 1-year prospective study. Scand. J. Immunol. 67, 71-76.
67. Hohwy, T., Otkjaer, K., Madsen, J., Søerensen, G., Nielsen, O., Vestergaard, C., Steiniche, T., Holmskov, U., and Lomholt, H. (2006). Surfactant protein D in atopic dermatitis and psoriasis. Exp. Dermatol. 15, 168-174.
68. Holmskov, U., Lawson, P., Teisner, B., Tornoel, I., Willis, A., Morgan, C., Koch, C., and Reid, K. B. (1997). Isolation and characterization of a new member of the scavenger receptor superfamily, glycoprotein-340(gp-340), as a lung surfactant protein-D binding molecules. J. Biol. Chem. 272, 13743-13749.
69. Holmskov, U., Thiel, S., and Jensenius, J. C. (2003). Collections and ficolins: humoral lectins of the innate immune defense. Annu. Rev. Immunol. 547-578.
70. Hussain, S., Wright, J., and Martin, W. II. (2003). Surfactant protein A decreases nitric oxide production by macrophages in a tumor necrosis factor-α-dependent mechanism. Am. J. Respir. Cell Mol. Biol. 28, 520-527.
71. Ishikawa, N., Hattori, N., Tanaka, S., Horimasu, Y., Haruta, Y., Yokoyama, A., Kohno, N., and Kinnula, V. L. (2011). Levels of surfactant proteins A and D and KL-6 are elevated in the induced sputum of chronic obstructive pulmonary disease patients: a sequential sputum analysis. Respiration. 82, 10-18.
72. Ito, Y., and Mason, R. J. (2010). The effect of interleukin-13 (IL-13) and interferon-γ (IFN-γ) on expression of surfactant proteins in adult human alveolar type II cells in vitro. Respir. Res. 157.
73. Jakel, A., Clark, H., Reid, K., and Sim, R. (2010). The human lung surfactant proteins A (SP-A) and D (SP-D) interact with apoptotic target cells by different binding mechanisms. Immunobiology 215, 551-558.
74. Janssen, W. J., McPhillips, K. A., Dickinson, M. G., Linderman, D. J., Morimoto, K., Xiao, Y. Q., and Oldham, K. M. (2008). Surfactant proteins A and D suppress alveolar macrophage phagocytosis via interaction with SIRP alpha. Am. J. Respir. Crit. Care Med. 178, 158-167.
75. Job, E., Deng, Y., Tate, M., Bottazzi, B., Crouch, E., Dean, M., Mantovani,A., Brooks, A. G., and Reading, P. C. (2010). Pandemic H1N1 influenza A viruses are resistant to the antiviral activities of innate immune proteins of the collectin and pentraxin superfamilies. J. Immunol. 185, 4284-4291.
76. Jounblat, R., Kadioglu, A., Iannelli, F., Pozzi, G., Eggleton, P., and Andrew, P. W. (2004). Binding and agglutination of Streptococcus pneumo-niae by human surfactant protein D (SP-D) vary between strains, but SP-D fails to enhance killing by neutrophils. Infect. Immun. 72, 709-716.
77. Kabha, K., Schmegner, J., Keisari, Y., Parolis, H., Schlepper-Schaefer, J., and Ofek, I. (1997). SP-A enhances phagocytosis of Klebsiella by interaction with capsular polysaccharides and alveolar macrophages. Am. J. Physiol. 272, L344-L352.
78. Kalina, M., Blau, H., Riklis, S., and Kravtsov, V. (1995). Interaction of surfactant protein A with bacterial lipopolysaccharide may affect some biological functions. Am. J. Physiol. 268, L144-L151.
79. Kankavi, O. (2006). Increased expression of surfactant protein A and D in rheumatoid arthritic synovial fluid (RASF). Croat. Med. J. 47, 155-161.
80. Kankavi, O., Ata, A., and Gungor, O. (2007). Surfactant proteins A and D in the genital tract of mares. Anim. Reprod. Sci. 98, 259-270.
81. Kawanami, O., Ferrans, V., and Crys-tal, R. (1982). Structure of alveolar epithelial cells in patients with fibrotic lung disorders. Lab. Invest. 46, 39-53.
82. Keirse, M. (1978). Biosynthesis and metabolism of prostaglandins in the pregnant human uterus. Adv. Prostaglandin Thromboxane Res. 4, 87-102.
83. Kim, M., Romero, R., Gervasi, M., Kim, J., Yoo, W., Lee, D., Mittal, P., Erez, O., Kusanovic, J. P., Hassan, S. S., and Kim, C. J. (2009). Wide-spread microbial invasion of the chorioamniotic membranes is a con-sequence and not a cause of intraamniotic infection. Lab. Invest. 89, 924-936.
84. Kinder, B., Brown, K., McCormack, F., Ix, J., Kervitsky, A., Schwarz, M., and King, T. E. Jr. (2009). Serum sSurfactant protein-A is a strong predictor of early mortality in idio-pathic pulmonary fibrosis. Chest 135, 1557-1563.
85. Kishore, U., Greenhough, T., Waters, P., Shrive,A. K.,Ghai,R.,Kamran,M. F., Bernal, A. L., Reid, K. B., Madan, T., and Chakraborty, T. (2006). Surfactant proteins SP-A and SP-D: struc-ture, function and receptors. Mol. Immunol. 43, 1293-1315.
86. Kishore, U., Strong, P., Perdikoulis, M. V., and Reid, K. B. (2001). A recom-binant homotrimer, composed of the alpha helical neck region of human surfactant protein D and C1q B chain globular domain, is an inhibitor of the classical complement pathway. J. Immunol. 166, 559-565.
87. Kishore, U., Wang, J. Y., Hoppe, H. J., and Reid, K. B. (1996). The alpha-helical neck region of human lung surfactant protein D is essential for the binding of the carbohydrate recognition domains to lipopolysaccharides and phos-pholipids. Biochem. J. 318(Pt 2), 505-511.
88. Kitaichi, N., Kitamura, M., Namba, K., Ishida, S., and Ohno, S. (2010). Elevation of surfactant protein D, a pulmonary disease biomarker, in the sera of uveitis patients with sarcoidosis. Jpn. J. Ophthalmol. 54, 81-84.
89. Kondo, A., Oketani, N., Maruyama, M., Taguchi, Y., Yamaguchi, Y., Miyao, H., and Mashima, I. (1998). Significance of serum surfactant protein-D (SP-D) level in patients with pulmonary tuberculosis. Kekkaku 73, 585-590.
90. Koopmans, J. G., van der Zee, J. S., Krop, E. J., Lopuhaä, C. E., Jansen, H. M., and Batenburg, J. J. (2004). Serum surfactant protein D is elevated in allergic patients. Clin. Exp. Allergy 34, 1827-1833.
91. Koziel, H., Phelps, D. S., Fishman, J. A., Armstrong, M. Y., Richards, F. F., and Rose, R. M. (1998). Surfactant protein-A reduces bind-ing and phagocytosis of pneumo-cystis carinii by human alveolar macrophages in vitro. Am. J. Respir. Cell Mol. Biol. 18, 834-843.
92. Kuan, S., Rust, K., and Crouch, E. (1992). Interactions of surfactant protein D with bacterial lipopolysac-charides. Surfactant protein D is an Escherichia coli-binding protein in bronchoalveolar lavage. J. Clin. Invest. 90, 97-106.
93. Kuang, Z., Hao, Y., Hwang, S., Zhang, S., Kim, E., Akinbi, H., Schurr, M. J., Irvin, R. T., Hassett, D. J., and Lau, G. W. (2011). The Pseudomonas aeruginosa flagellum confers resistance to pulmonary sSurfactant protein-A by impacting the production of exoproteases through quorum-sensing. Mol. Microbiol. 79, 1220-1235.
94. Kucejko, W., Chyczewska, E., Naum-nik, W., and Ossolinska, M. (2009). Concentration of surfactant protein D, Clara cell protein CC-16 and IL-10 in bronchoalveolar lavage (BAL) in patients with sar-coidosis, hypersensivity pneumoni-tis and idiopathic pulmonary fibro-sis. Folia Histochem. Cytobiol. 47, 225-230.
95. Kudo, K., Sano, H., Takahashi, H., Kuronuma, K., Yokota, S., Fujii, N., Shimada, K., Yano, I., Kumazawa, Y., Voelker, D. R., Abe, S., and Kuroki, Y. (2004). Pulmonary collectins enhance phagocytosis of Mycobac-terium avium through increased activity of mannose receptor. J. Immunol. 172, 7592-7602.
96. Kuroki, Y., and Akino, T. (1991). pulmonary surfactant protein A (SP-A) specifically binds dipalmitoylphos-phatidylcholine. J. Biol. Chem. 266, 3068-3073.
97. Kuroki,Y., Takahashi, H., Chiba, H., and Akino, T. (1998). Surfactant proteins A and D: disease markers. Biochim. Biophys. Acta. 1408, 334-345.
98. Kuroki, Y., Tsutahara, S., Shijubo, N., Takahashi, H., Shiratori, M., Hattori, A., Honda, Y., Abe, S., and Akino, T. (1993). Elevated levels of lung surfactant protein A in sera from patients with idiopathic pulmonary fibrosis and pulmonary alveolar proteinosis. Am. Rev. Respir. Dis. 147, 723-729.
99. Kuronuma, K., Sano, H., Kato, K., Kudo, K., Hyakushima, N., and Yokota, S. (2004). Pulmonary surfactant protein A augments the phagocy-tosis of Streptococcus pneumonia by alveolar macrophages through a casein kinase 2-dependent increase of cell surface localization of scav-enger receptor A. J. Biol. Chem. 279, 21421-21430.
100. Kushner, I., and Somerville, J. (1971). Permeability of human synovial membrane to plasma proteins. Relationship to molecular size and inflammation. Arthritis Rheum. 14, 560-570.
101. LaForce, F., Kelly, W., and Huber, G. (1973). Inactivation of Staphylococci by alveolar macrophages with preliminary observations on the importance of alveolar lining mate-rial. Am. Rev. Respir. Dis. 108, 784-790.
102. Lahra, M., and Jeffery, H. (2004). A fetal response to chorioamnionitis is associated with early survival after preterm birth. Am.J.Obstet. Gynecol. 190, 147-151.
103. Larsen, L., Clausen, H., and Jonsson, L. (2002). Stereologic examination of placentas from mothers who smoke during pregnancy. Am.J.Obstet. Gynecol. 186, 531-537.
104. Lawson, P., and Reid, K. (2000). The roles of surfactant proteins A and D in innate immunity. Immunol. Rev. 173, 66-78.
105. Lee, D., Romero, R., Kim, C., Chaiworapongsa, T., Tarca, A., Lee, J., Suh, Y. L., Mazaki-Tovi, S., Vaisbuch, E., Mittal, P., Draghici, S., Erez, O., Kusanovic, J. P., Hassan, S. S., and Kim, J. S. (2010). Surfactant protein-A as an anti-inflammatory component in the amnion: implications for human pregnancy. J. Immunol. 184, 6479-6491.
106. Lee, H., Kang, H., Woo, J., Chae, S., Lee, S., and Hwang, S. (2006). Upreg-ulation of surfactant protein A in chronic rhinosinusitis. Laryngoscope 116, 328-330.
107. Lekkala, M., LeVine, A., Linke, M., Crouch, E., Linders, B., Brummer, E., and Stevens, D. A. (2006). Effect of lung surfactant collectins on bron-choalveolar macrophage interaction with Blastomyces dermatitidis: inhi-bition of tumor necrosis factor alpha production by surfactant protein D. Infect. Immun. 74, 4549-4556.
108. LeVine, A. M., Bruno, M. D., Huelsman, K. M., Ross, G. F., Whitsett, J. A., and Korfhagen, T. R. (1997). Surfactant protein A-deficient mice are susceptible to group B strepto-coccal infection. J. Immunol. 158, 4336-4340.
109. LeVine, A. M., Kurak, K. E., Wright, J. R., Watford, W. T., Bruno, M. D., Ross, G. F., Whitsett, J. A., and Korfhagen, T. R. (1999). Surfactant protein-A binds group B strepto-coccus enhancing phagocytosis and clearance from lungs of surfactant protein-A-deficient mice. Am. J. Respir. Cell Mol. Biol. 20, 279-286.
110. Leth-Larsen, R., Zhong, F., Chow, V. T., Holmskov, U., and Lu, J. (2007). The SARS coronavirus spike glyco-protein is selectively recognized by lung surfactant protein D and acti-vates macrophages. Immunobiology 212, 201-211.
111. Lichtenberger, L. M., Graziani, L. A., Dial, E. J., and Butler, B. D. (1983). Role of surface-active phospholipids in gastric cytoprotection. Science 219, 1327-1329.
112. Lim, B., Wang, J., Holmskov, U., Hoppe, H., and Reid, K. (1994). Expression of the carbohydrate recognition domain of lung surfactant protein D and demonstration of its bind-ing to lipopolysaccharides of gram-negative bacteria. Biochem. Biophys. Res. Commun. 202, 1674-1680.
113. Limper,A. H., Crouch, E. C., O'Riordan, D. M., Chang, D., Vuk-Pavlovic, Z., Standing J. E., Kwon, K. Y., and Adlakha, A. (1995). Surfactant protein-D modulates interaction of Pneumocystis carinii with alveolar macrophages. J. Lab. Clin. Med. 126, 416-422.
114. Lin, F., Chen, Y., and Chang, S. (2008). Clinical importance of bron-choalveolar lavage fluid and blood cytokines, surfactant protein D, and Kerbs von Lungren 6 anti-gen in idiopathic pulmonary alveolar proteinosis. Mayo Clin. Proc. 83, 1344-1349.
115. Lin, Z., deMello, D., Phelps, D., Koltun, W., Page, M., and Floros, J. (2001). Both human SP-A1 and Sp-A2 genes are expressed in small and large intestine. Pediatr. Pathol. Mol. Med. 5, 367-386.
116. Litvack, M., and Palaniyar, N. (2010). Review: soluble innate immune pattern-recognition proteins for clearing dying cells and cellular components: implications on exac-erbating or resolving inflammation. Innate Immun. 16, 191-200.
117. Lomas, D., Silverman, E., Edwards, L., Locantore, N., Miller, B., Horstman, D., and Tal-Singer, R. (2009). Serum surfactant protein D is steroid sen-sitive and associated with exacerbations of COPD. Eur. Respir. J. 34, 95-102.
118. MacNeill, C., Umstead, T., Phelps, D., Lin,Z.,Floros,J.,Shearer,D.,Shearer, D. A., and Weisz, J. (2004). Surfactant protein A, an innate immune factor, is expressed in the vagi-nal mucosa and is present in vagi-nal lavage fluid. Immunology 111, 91-99.
119. Madan, T., Eggleton, P., Kishore, U., Strong, P., Aggrawal, S., Sarma, P., and Reid, K. B. (1997a). Binding of pulmonary surfactant proteins A and D to Aspergillus fumiga-tus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages. Infect. Immun. 65, 3171-3179.
120. Madan, T., Kishore, U., Shah, A., Eggleton, P., Strong, P., Wang, J. Y., Aggrawal, S. S., Sarma, P. U., and Reid, K. B. (1997b). Lung surfactant proteins A and D can inhibit specific IgE binding to the allergens of Aspergillus fumi-gatus and block allergen-induced histamine release from human basophils. Clin. Exp. Immunol. 110, 241-249.
121. Madan, T., Kishore, U., Singh, M., Strong, P., Hussain, E., Reid, K., and Sarma, P. U. (2001). Protective role of lung surfactant protein D in a murine model of invasive pulmonary aspergillosis. Infect. Immun. 69, 2728-2731.
122. Madan, T., Reid, K. B., Clark, H., Singh, M., Nayak, A., Sarma, P. U., Haw-good, S., and Kishore, U. (2010). Susceptibility of mice genetically deficient in SP-A or SP-D gene to invasive pulmonary aspergillosis. Mol. Immunol. 47, 1923-1930.
123. Madan, T., Reid, K. B., Singh, M., Sarma, P. U., and Kishore, U. (2005). Sus-ceptibility of mice genetically defi-cient in the surfactant protein (SP)-A or SP-D gene to pulmonary hyper-sensitivity induced by antigens and allergens of Aspergillus fumigatus. J. Immunol. 174, 6943-6954.
124. Madsen, J., Kliem, A., Tornoe, I., Skjodt, K., Koch, C., and Holmskov, U. (2000). Localization of lung surfactant protein D on mucosal surfaces in human tissues. J. Immunol. 164, 5866-5870.
125. Madsen, J., Tornoe, I., Nielsen, O., Koch, C., Steinhilber, W., and Holmskov, U. (2003). Expression and localiza-tion of lung surfactant protein A in human tissues. Am. J. Respir. Cell Mol. Biol. 29, 591-597.
126. Mahajan, L., Madan, T., Kamal, N., Singh, V., Sim, R., Telang, S., Ram-chand, C. N., Waters, P., Kishore, U., and Sarma, P. U. (2008). Recombinant surfactant protein-D selectively increases apoptosis in eosinophils of allergic asthmatics and enhances uptake of apoptotic eosinophils by macrophages. Int. Immunol. 20, 993-1007.
127. Malhotra, R., Haurum, J., Thiel, S., Jensenius, J., and Sim, R. (1993). Pollen grains bind to lung alveolar type II cells (A549) via lung surfactant proteinA (SP-A). Biosci. Rep. 13, 79-90.
128. Malhotra, R., Haurum, J. S., Thiel, S., and Sim, R. B. (1994). Binding of human collectins (SP-A and MBP) to influenza virus. Biochem. J. 304, 455-461.
129. Malloy, J., Veldhuizen, R., Thibodeaux, B., O'Callaghan, R., and Wright, J. (2005). Pseudomonas aeruginosa protease IV degrades surfactant proteins and inhibits surfactant host defense and biophysical functions. Am. J. Physiol. Lung Cell. Mol. Phys-iol. 288, L409-L418.
130. Manz-Keinke, H., Plattner, H., and Schlepper-Schäfer, J. (1992). Lung surfactant protein A (SP-A) enhances serum-independent phagocytosis of bacteria by alveolar macrophages. Eur. J. Cell Biol. 57, 95-100.
131. Mazur, W., Toljamo, T., Ohlmeier, S., Vuopala, K., Nieminen, P., Kobayashi, H., and Kinnula, V. L. (2011). Elevation of surfactant protein A in plasma and sputum in cigarette smokers. Eur. Respir. J. 38, 277-284.
132. McCormack, F., Festa, A., Andrews, R., Linke, M., and Walzer, P. (1997). The carbohydrate recognition domain of surfactant protein A mediates bind-ing to the major surface glycoprotein of Pneumocystis carinii. Biochemistry 36, 8092-8099.
133. McCormack, F., Gibbons, R., Ward, S., Kuzmenko, A., Wu, H., and Deepe, G. (2003). Macrophage-independent fungicidal action of the pulmonary collectins. J. Biol. Chem. 278, 36250-36256.
134. McNeely, T. B., and Coonrod, J. D. (1993). Comparison of the opsonic activity of human surfactant protein A for Staphylococcus aureus and Streptococcus pneumoniae with rabbit and human macrophages. J. Infect. Dis. 167, 91-97.
135. McNeely, T., and Coonrod, J. (1994). Aggregation and opsonization of type A but not type B Haemophilus influenza by surfactant protein A. Am. J. Respir. Cell Mol. Biol. 11, 114-122.
136. Meschi, J. C., Crouch, E. C., Skol-nik, P., Yahya, K., Holmskov, U., Leth-Larsen, R., and Tornoe, I. (2005). Surfactant protein D binds to human immunodeficiency virus (HIV) envelope protein gp120 and inhibits HIV replication. J. Gen. Virol. 86(Pt 11), 3097-3107.
137. Miyamura, K., Malhotra, R., Hoppe, H., Reid, K., Phizackerley, P., Macpher-son, P., and López Bernal, A. (1994). Surfactant proteins A (SP-A) and D (SP-D): levels in human amniotic fluid and localization in the fetal membranes. Biochim. Biophys. Acta 1210, 303-307.
138. Mo, Y., Kankavi, O., Masci, P., Mellick, G., Whitehouse, M., Boyle, G., Parsons, P. G., Roberts, M. S., and Cross, S. E. (2007). SSurfactant protein expression in human skin: evidence and impli-cations. J. Invest. Dermatol. 127, 381-386.
139. More, J., Voelker, D., Silveira, L., Edwards, M., Chan, E., and Bowler, R. (2010). Smoking reduces sSurfactant protein D and phospho-lipids in patients with and without chronic obstructive pulmonary disease. BMC Pulm. Med. 10, 53. doi:10.1186/1471-2466-10-53
140. Mori, K., Kurihara, N., Hayashida, S., Tanaka, M., and Ikeda, K. (2002). The intrauterine expression of sSurfactant protein D in the terminal airways of human fetuses compared with surfactant protein A. Eur. J. Pediatr. 161, 431-434.
141. Murakami, S., Iwaki, D., Mitsuzawa, H., Sano, H., Takahashi, H., Voelker, D., Mellick, G. D., Whitehouse, M. W., Boyle, G. M., Parsons, P. G., Roberts, M. S., and Cross, S. E. (2002). Surfactant protein A inhibits peptidoglycan-induced tumor necrosis factor-secretion in U937 cells and alveolar macrophages by direct interaction with Toll-like receptor 2. J. Biol. Chem. 277, 6830-6837.
142. Noah, T., Murphy, P., Alink, J., Leigh, M., Hull, W., Stahlman, M., and Whitsett, J. A. (2003). Bron-choalveolar lavage fluid surfactant protein-A and surfactant protein-D are inversely related to inflam-mation in early cystic fibrosis. Am. J. Respir. Crit. Care Med. 168, 685-691.
143. Nomori, H., Horio, H., Fuyuno, G., Kobayashi, R., Morinaga, S., and Suemasu, K. (1998). Serum surfactant protein A levels in healthy individuals are increased in smokers. Lung 176, 355-361.
144. Norwitz, E., López Bernal, A., and Starkey, P. (1992a). Tumor necrosis factor-alpha selectively stimu-lates prostaglandin F2 alpha production by macrophages in human term decidua. Am. J. Obstet. Gynecol. 167, 815-820.
145. Norwitz, E., Starkey, P., and López Bernal, A. (1992b). Prostaglandin D2 production by term human decidua: cellular origins defined using flow cytometry. Obstet. Gynecol. 80, 440-445.
146. Oberley, R., Goss, K., Ault, K., Crouch, E., and Snyder, J. (2004). Surfactant protein D is present in the human female reproductive tract and inhibits Chlamydia trachoma-tis infection. Mol. Hum. Reprod. 10, 861-870.
147. Oberley, R. E., Goss, K. L., Hoffmann, D. S., Ault, K. A., Neff, T. L., Ramsey, K. H., Ramsey, K. H., and Snyder, J. M. (2007). Regu-lation of surfactant protein D in the mouse female reproductive tract in vivo. Mol. Hum. Reprod. 13, 863-868.
148. Ohlmeier, S., Vuolanto, M., Toljamo, T., Vuopala, K., Salmenkivi, K., Myllärniemi, M., and Kinnula, V. L. (2008). Proteomics of human lung tissue identifies surfactant protein A as a marker of chronic obstructive pulmonary disease. J. Proteome Res. 7, 5125-5132.
149. Ohmer-Schröck, D., Schlatterer, C., Plattner, H., and Schlepper-Schäfer, J. (1995). Lung surfactant protein A (SP-A) activates a phosphoinosi-tide/calcium signaling pathway in alveolar macrophages. J. Cell Sci. 108, 3695-3702.
150. Okita, J., MacDonald, P., and John-ston, J. (1982). Mobilization of arachidonic acid from specific glyc-erophospholipids of human fetal membranes during early labor. J. Biol. Chem. 257, 14029-14034.
151. Ooi, E., Wormald, P., Carney, A., James, C., and Tan, L. (2007). Surfactant protein d expression in chronic rhi-nosinusitis patients and immune responses in vitro to Aspergillus and alternaria in a nasal explant model. Laryngoscope 117, 51-57.
152. O'Riordan, D. M., Standing, J. E., Kwon, K. Y., Chang, D., Crouch, E. C., and Limper, A. H. (1995). SSurfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages. J. Clin. Invest. 95, 2699-2710.
153. Paananen, R., Sormunen, R., Glumoff, V., van Eijk, M., and Hallman, M. (2001). Surfactant proteins A and D in Eustachian tube epithelium. Am. J. Physiol. Lung Cell. Mol. Physiol. 281, L660-L667.
154. Palaniyar, N., Clark, H., Nadesalingam, J., Shih, M. J., Hawgood, S., and Reid, K. B. (2005). Innate immune collectin surfactant protein D enhances the clearance of DNA by macrophages and mini-mizes anti-DNA antibody genera-tion. J. Immunol. 174, 7352-7358.
155. Pasula, R., Downing, J. F., Wright, J. R., Kachel, D. L., Davis, T. E. Jr., and Martin, W. J. (1997). Surfactant protein A (SP-A) mediates attachment of Mycobacterium tuberculosis to murine alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 17, 209-217.
156. Pasula, R., Wright, J., Kachel, D., and Martin, W. II. (1999). Surfactant protein A suppresses reactive nitrogen intermediates by alveolar macrophages in response to Mycobacterium tuberculosis. J. Clin. Invest. 103, 483-490.
157. Pejovic, M., Stankovic, A., and Mitrovic, D. (1995). Determination of the apparent synovial permeability in the knee joint of patients suffering from osteoarthritis and rheuma-toid arthritis. Br. J. Rheumatol. 34, 520-524.
158. Piboonpocanun, S., Mitsuzawa, H., Martin, W., Murphy, R., Harbeck, R., and Voelker, D. (2005). Surfactant protein A binds Mycoplasma pneu-moniae with high affinity and atten-uates its growth by recognition of disaturated phosphatidylglycerol. J. Biol. Chem. 280, 9-17.
159. Pikaar, J., Voorhout, W., van Golde, L., Verhoef, J., Van Strijp, J., and van Iwaarden, J. (1995). Opsonic activities of surfactant proteins A and D in phagocytosis of gram-negative bacteria by alveolar macrophages. J. Infect. Dis. 172, 481-489.
160. Pryhuber, G., Hull, W., Fink, I., McMahan, M., and Whitsett, J. (1991). Ontogeny of surfactant proteins A and B in human amniotic fluid as indices of fetal lung maturity. Pediatr. Res. 30, 597-605.
161. Ragas, A., Roussel, L., Puzo, G., and Rivière, M. (2007). The Mycobacterium tuberculosis cell-surface glycoprotein apa as a potential adhesin to colonize target cells via the innate immune system pulmonary C-type lectin sSurfactant protein A. Biol. Chem. 282, 5133-5142.
162. Reading, P. C., Holmskov, U., and Anders, E. M. (2004). Antiviral activity of bovine collectins against rotaviruses. J. Gen. Virol. 79(Pt 9), 2255-2263.
163. Reading, P., Morey, L., Crouch, E., and Anders, E. (1997). Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice. J. Virol. 71, 8204-8212.
164. Restrepo, C. I., Dong, Q., Savov, J., Mariencheck, W. I., and Wright, J. R. (1999). Surfactant protein D stimulates phagocytosis of Pseudomonas aeruginosa by alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 21, 576-585.
165. Rosseau, S., Guenther, A., Seeger, W., and Lohmeyer, J. (1997). Phagocytosis of viable Candida albicans by alveolar macrophages: lack of opsonin function of surfactant protein A. J. Infect. Dis. 175, 421-428.
166. Rubio, S., Lacaze-Masmonteil, T., Chailley-Heu, B., Kahn, A., Bour-bon, J., and Ducroc, R. (1995). Pulmonary surfactant protein A (SP-A) is expressed by epithelial cells of small and large intestine. J. Biol. Chem. 270, 12162-12169.
167. Sago, H., Sugimoto, K., Fujii, S., Iinuma, K., Yamashita, K., Kitagawa, M., and Terashima, Y. (1993). Dynamic changes in stress fiber expression in rat uterine vein endothelial cells associated with pregnancy. Microvasc. Res. 46, 178-189.
168. Sano, H., Kuronuma, K., Kudo, K., Mitsuzawa, H., Sato, M., Murakami, S., and Kuroki, Y. (2007). Regulation of inflammation and bacterial clear-ance by lung collectins. Respirology 11, S46-S50.
169. Sano, H., Nagai, K., Tsutsumi, H., and Kuroki, Y. (2003). Lactoferrin and surfactant protein A exhibit distinct binding specificity to F protein and differently modulate respi-ratory syncytial virus infection. Eur. J. Immunol. 33, 2894-2902.
170. Sano, H., Sohma, H., Muta, T., Nomura, S.,Voelker, D., and Kuroki,Y. (1999). Pulmonary surfactant protein A modulates the cellular response to smooth and rough lipopolysaccha-rides by interaction with CD14. J. Immunol. 163, 387-395.
171. Sasaki, R., Soejima, T., Matsumoto, A., Maruta, T., Yamada, K., Ota, Y., Kawabe, T., Nishimura, H., Sakai, E., Ejima, Y., and Sugimura, K. (2001). Clinical significance of serum pulmonary surfactant proteins a and d for the early detection of radiation pneumonitis. Int. J. Radiat. Oncol. Biol. Phys. 50, 301-307.
172. Sato, A., Whitsett, J., Scheule, R., and Ikegami, M. (2010). Surfactant protein-d inhibits lung inflam-mation caused by ventilation in premature newborn lambs. Am. J. Respir. Crit. Care Med. 181, 1098-1105.
173. Sato, M., Sano, H., Iwaki, D., Kudo, K., Konishi, M., Takahashi, H., Taka-hashi, T., Imaizumi, H., Asai, Y., and Kuroki, Y. (2003). Direct binding of Toll-like receptor 2 to zymosan, and zymosan-induced NF-B activation and TNF-secretion are down-regulated by lung collectin surfactant protein A. J. Immunol. 171, 417-425.
174. Sawada, K., Ariki, S., Kojima T., Saito, A., Yamazoe, M., Nishitani, C., Shimizu, T., Takahashi, M., Mitsuzawa, H., Yokota, S., Sawada, N., Fujii, N., Takahashi, H., and Kuroki, Y. (2010). Pulmonary col-lectins protect macrophages against pore-forming activity of Legionella pneumophila and suppress its intra-cellular growth. J. Biol. Chem., 285, 8434-8443.
175. Schagat, T., Wofford, J., and Wright, J. (2001). Surfactant protein A enhances alveolar macrophage phagocytosis of apoptotic neutrophils. J. Immunol. 166, 2727-2733.
176. Schelenz, S., Malhotra, R., Sim, R. B., Holmskov, U., and Bancroft, G. J. (1995). Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells. Infect. Immun. 63, 3360-3366.
177. Schett, G., Zwerina, J., and Firestein, G. (2008). The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis. Ann. Rheum. Dis. 67, 909-916.
178. Sever-Chroneos, Z., Krupa, A., Davis, J., Hasan, M., Yang, C. H., Szeliga, J., Herrmann, M., Hussain, M., Geis-brecht, B. V., Kobzik, L., and Chro-neos, Z. C. (2011). Surfactant protein A (SP-A)-mediated clearance of Staphylococcus aureus involves binding of SP-A to the staphylococcal adhesin eap and the macrophage receptors SP-A receptor 210 and scavenger receptor class A. J. Biol. Chem. 286, 4854-4870.
179. Shakoori, T., Sin, D., Ghafoor, F., Bashir, S., and Bokhari, S. (2009). Serum surfactant protein D during acute exacerbations of chronic obstructive pulmonary disease. Dis. Markers 27, 287-294.
180. Shepherd, V. L. (2002). Pulmonary surfactant protein D: a novel link between innate and adaptive immu-nity. Am. J. Physiol. Lung Cell. Mol. Physiol. 282, L516-L517.
181. Silhavy, T. J., Kahne, D., and Walker, S. (2010). The bacterial cell envelope. Cold Spring Harb. Perspect. Biol. 2, a000414.
182. Simani, A., Inoue, S., and Hogg, J. (1974). Penetration of the respiratory epithelium of guinea pigs fol-lowing exposure to cigarette smoke. Lab. Invest. 31, 75-81.
183. Sin, D., Man, S., Marciniuk, D., Ford, G., FitzGerald, M., Wong, E., York, E., Mainra, R. R., Ramesh, W., Melenka, L. S., Wilde, E., Cowie, R. L., Williams, D., Gan, W. Q., and Rousseau, R. (2008). The effects of fluticasone with or without salmeterol on systemic biomark-ers of inflammation in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 177, 1207-1201.
184. Singh, M., Madan, T., Waters, P., Parida, S., Sarma, P., and Kishore, U. (2003). Protective effects of a recombinant fragment of human surfactant protein D in a murine model of pulmonary hypersensitivity induced by dust mite allergens. Immunol. Lett. 86, 297-307.
185. Singh, M., Madan, T., Waters, P., Sonar, S., Singh, S. K., Kamran, M. F., and Bernal, A. L. (2009). Therapeutic effects of recombinant forms of full-length and truncated human surfactant protein D in a murine model of invasive pulmonary aspergillosis. Mol. Immunol. 46, 2363-2369.
186. Skinner, M., Schlosser, R., Lathers, D., Neal, J., Woodworth, B., Hall, J., Newton, D. A., and Baatz, J. E. (2007). Innate and adaptive mediators in cystic fibrosis and allergic fungal rhinosinusitis. Am. J. Rhinol. 2007, 538-541.
187. Sorensen, G., Madsen, J., Kejling, K., Tornoe, I., Nielsen, O., Townsend, P., Poulain, F., Nielsen, C. H., Reid, K. B., Hawgood, S., Falk, E., and Holm-skov, U. (2006). Surfactant protein D is proatherogenic in mice. Am. J. Physiol. Heart Circ. Physiol. 290, H2286-H2294.
188. Stahlman, M., Gray, M., Hull, W., and Whitsett,J. (2002). Immunolocalization of surfactant protein-D (SP-D) in human fetal, newborn, and adult tissues. J. Histochem. Cytochem. 50, 651-660.
189. Tenner, A., Robinson, S., Borchelt, J., and Wright, J. (1989). Human pulmonary surfactant protein (SP-A), a protein structurally homologous to C1q, can enhance FcR-and CR1-mediated phagocytosis. J. Biol. Chem. 264, 13923-13928.
190. Tino, M., and Wright, J. (1999). Glycoprotein-340 binds surfactant protein-A (SP-A) and stimulates alveolar macrophage migration in an SP-A-independent manner. Am. J. Respir. Cell Mol. Biol. 20, 759-768.
191. Trinder, P., Hickling, T., Sim, R., Brackertz, D., Loos, M., and Maeurer, M. (2000). Humoral autoreactivity directed against surfactant protein-A (SP-A) in rheumatoid arthritis synovial fluids. Clin. Exp. Immunol. 120, 183-187.
192. van de Wetering, J., van Eijk, M., van Golde, L., Hartung, T., van Strijp, J., and Batenburg, J. (2001). Characteristics of surfactant protein A and D binding to lipoteichoic acid and peptidoglycan, 2 major cell wall components of gram-positive bacte-ria. J. Infect. Dis. 184, 1143-1151.
193. van de Wetering, J. K., van Remoortere, A.,Vaandrager,A. B., Batenburg, J. J., van Golde, L. M., Hokke, C. H., and van Hellemond, J. J. (2004a). SSurfactant protein D binding to termi-nal alpha1-3-linked fucose residues and to Schistosoma mansoni. Am. J. Respir. Cell Mol. Biol. 31, 565-572.
194. van de Wetering, J. K., Coenjaerts, F. E., Vaandrager, A. B., van Golde, L. M., and Batenburg, J. J. (2004b). Aggre-gation of Cryptococcus neoformans by surfactant protein D is inhib-ited by its capsular component glucuronoxylomannan. Infect Immun. 72, 145-153.
195. van Iwaarden, F, Welmers, B., Verhoef., J., Haagsman, H. P., and van Golde, L. M. (1990). Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 2, 91-98.
196. van Iwaarden, J., Pikaar, J., Storm, J., Brouwer, E., Verhoef, J., Oosting, R., van Golde, L. M., and van Strijp, J. A. (1994). Binding of surfactant protein A to the lipid A moiety of bacte-rial lipopolysaccharides. Biochem. J. 303, 407-411.
197. van Iwaarden, J., van Strijp, J., Ebskamp, M., Welmers, A., Verhoef, J., and van Golde, L. (1991). Surfactant protein A is opsonin in phagocytosis of herpes simplex virus type 1 by rat alveolar macrophages. Am. J. Physiol. 261(2 Pt 1), L204-L209.
198. van Iwaarden, J., van Strijp, J., Visser, H., Haagsman, H., Verhoef, J., and van Golde, L. (1992). Binding of surfactant protein A (SPA) to herpes simplex virus type 1-infected cells is mediated by the carbohydrate moiety of SP-A. J. Biol. Chem. 267, 25039-25043.
199. van Rozendaal, B., van Spriel, A., van De Winkel, J., and Haagsman, H. (2000). Role of pulmonary surfactant protein D in innate defense against Candida albicans. J. Infect. Dis. 182, 917-922.
200. Vandivier, R., Ogden, C., Fadok, V. A., Hoffmann, P., Brown, K., Botto, M., Walport, M. J., Fisher, J. H., Hen-son, P. M., and Greene, K. E. (2002). Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex. J. Immunol. 169, 3978-3986.
201. Vuk-Pavlovic, Z., Standing, J. E., Crouch, E. C., and Limper, A. H. (2001). Carbohydrate recogni-tion domain of surfactant protein D mediates interactions with Pneumocystis carinii glycoproteinA. Am. J. Respir. Cell Mol. Biol. 24, 475-484.
202. Walenkamp, A., Verheul, A., Scharringa, J., and Hoepelman, I. (1999). pulmonary surfactant protein A binds to Cryptococcus neoformans without promoting phagocytosis. Eur. J. Clin. Invest. 29, 83-92.
203. Wang, J., Shieh, C., You, P., Lei, H., and Reid,K. (1998). Inhibitory effect of pulmonary surfactant proteins A and D on allergen-induced lym-phocyte proliferation and histamine release in children with asthma. Am. J. Respir. Crit. Care Med. 158, 510-518.
204. Wang, J. Y., Kishore, U., Lim, B. L., Strong, P., and Reid, K. B. (1996). Interaction of human lung sSurfactant proteins A and D with mite (Dermatophagoides pteronyssi-nus) allergens. Clin. Exp. Immunol. 106, 367-373.
205. Weaver, T., and Whitsett, J. (1991). Function and regulation of expression of pulmonary surfactant-associated proteins. Biochem. J. 273, 249-264.
206. Weikert, L. F., Edwards, K., Chroneos, Z. C.,Hager,C.,Hoffman,L.,and Shepherd, V. L. (1997). SP-A enhances uptake of bacillus Calmette-Guérin by macrophages through a specific SP-A receptor. Am. J. Physiol. 272, L989-L995.
207. Weikert, L., Lopez, J., Abdolrasulnia, R., Chroneos, Z., and Shepherd, V. (2000). Surfactant protein A enhances mycobacterial killing by rat macrophages through a nitric oxide-dependent pathway. Am. J. Physiol. Lung Cell. Mol. Physiol. 279, L216-L223.
208. Wells, A., Hansell, D., Harrison, N., Lawrence, R., Black, C., and du Bois, R. (1993). Clearance of inhaled 99mTc-DTPA predicts the clinical course of fibrosing alveolitis. Eur. Respir. J. 6, 797-802.
209. Williams, M. D., Wright, J. R., March, K. L., and Martin, W. J. (1996). Human surfactant protein A enhances attachment of Pneumocystis carinii to rat alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 14, 232-238.
210. Winkler, C., Atochina-Vasserman, E., Holz, O., Beers, M., Erpenbeck, V., Krug, N., Roepcke, S., Lauer, G., Elmlinger, M., and Hohlfeld, J. M. (2011). Comprehensive characterisation of pulmonary and serum sSurfactant protein D in COPD. Respir. Res. 12, 12-29.
211. Woodworth, B., Lathers, D., Neal, J., Skinner, M., Richardson, M., Young, M. R., and Schlosser, R. J. (2006). Immunolocalization of surfactant protein A and D in sinonasal mucosa. Am. J. Rhinol. 20, 461-465.
212. Woodworth, B. A., Neal, J. G., Newton, D., Joseph, K., Kaplan, A. P., Baatz, J. E., and Schlosser, R. J. (2007a). SSurfactant protein A and D in human sinus mucosa: a preliminary report. ORL J. Otorhinolaryngol. Relat. Spec. 69, 57-60.
213. Woodworth, B., Wood, R., Baatz, J., and Schlosser, R. (2007b). Sinonasal sSurfactant protein A1, A2, and D gene expression in cystic fibrosis: a pre-liminary report. Otolaryngol. Head Neck Surg. 137, 34-38.
214. Wootten, C., Labadie, R., Chen, A., and Lane, K. (2006). Differential expression of surfactant protein A in the nasal mucosa of patients with allergy symptoms. Arch. Otolaryngol. Head Neck Surg. 132, 1001-1007.
215. Wright, J. R. (2005). Immunoregula-tory functions of surfactant proteins. Nat. Rev. Immunol. 1, 58-68.
216. Wu, H., Kuzmenko, A., Wan, S., Schaf-fer, L., Weiss, A., Fisher, J., Kim, K. S., and McCormack, F. X. (2003). SSurfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. J. Clin. Invest. 111, 1589-1602.
217. Wu, Y., Liu, Z., Wei, R., Pan, S., Mao, N., Chen, B., Han, J. J., Zhang, F. S., Holmskov, U., Xia, Z. L., de Groot, P. G., Reid, K. B., Xu, W. B., and Sorensen, G. L. (2009). Ele-vated plasma surfactant protein D (SP-D) levels and a direct correlation with anti-severe acute respiratory syndrome coronavirus-specific IgG antibody in SARS patients. Scand. J. Immunol. 69, 508-515.
218. Wyllie, A. H., Kerr, J. F., and Currie, A. R. (1980). Cell death: the signif-icance of apoptosis. Int. Rev. Cytol. 68, 251-306.
219. Yanaba, K., Hasegawa, M., Takehara, K., and Sato, S. (2004). Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers for monitoring the activity of pulmonary fibrosis. J. Rheumatol. 31, 1112-1120.
220. Yong, S. J., Vuk-Pavlovic, Z., Standing, J. E., Crouch, E. C., and Limper, A. H. (2003). Surfactant protein D-mediated aggregation of Pneu-mocystis carinii impairs phagocyto-sis by alveolar macrophages. Infect. Immun. 71, 1662-1671.
221. Zimmerman, P., Voelker, D., McCormack, F., Paulsrud, J., and Martin,W. (1992). 120 kDa surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A. J. Clin. Invest. 89, 143-149.